The Neoantigen Based Therapies Summit is a conference that covers topics such as:
- Targeting ERAP1 to Alter the Cancer Immunopeptidome
- Taking a Comparative Oncological Perspective to Understand the Significance of Neoantigens in Cancer Immunotherapy
- Maximizing Immunogenicity to Drive Clinical Development & Success
- Evaluating Current Neoantigen Identification & Prediction Approaches to Reveal Lessons Learned from Pre-clinical Studies
- The Challenges of Checkpoint Inhibitors: The ATLAS™ Bioassay Method for Identification of Neoantigens & Inhibigens
- Comparison of the Different Delivery Platforms
- Scaling up Safe & Efficacious TCR Therapies Using the Sleeping Beauty Platform
- Overcoming Immunosuppression in the Solid Tumor Microenvironment
- Identifying Functional Neo-antigens by HTS: the Unique, the Common, the Exotic
- Mechanisms of Immune Resistance in NSCLC Through Analysis of the T Cell Repertoire
The Neoantigen Based Therapies Summit might be held in Dec 2024.
